This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n18http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n12http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0019995/price-of-originator/
n8http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0019995/reimbursement/
skoshttp://www.w3.org/2004/02/skos/core#
n17http://linked.opendata.cz/resource/sukl/indgroup/
n19http://linked.opendata.cz/resource/sukl/packing/
n15http://linked.opendata.cz/resource/sukl/company/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0019995/
n5http://linked.opendata.cz/resource/sukl/active-ingredient/
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0019995/core-reimbursement/
n9http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0019995/price/
n13http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://www.sukl.cz/modules/medication/
n16http://linked.opendata.cz/resource/sukl/df/
n11http://linked.opendata.cz/resource/atc/

Statements

Subject Item
n2:0019995
rdf:type
n3:MedicinalProductPackaging
dcterms:title
GABAPENTIN-TEVA 400 MG
skos:notation
0019995
n3:hasATCCode
n11:N03AX12
n3:hasActiveIngredient
n5:GABAPENTINUM
n3:hasDefinedDailyDose
n4:ddd
n3:hasDosageForm
n16:CPS-DUR-POR
n3:hasPackagingSize
50
n3:hasPacking
n19:BLI
n3:hasRegistrationHolder
n15:TPPCZ
n3:hasRegistrationState
n14:R
n3:hasRouteOfAdministration
n18:POR
n3:hasStrength
400MG
n3:hasIndicationGroup
n17:21
n3:hasSpecializationRestriction
n13:blank-cell
n3:containsDefinedDailyDoses
11.111100196838378906
n3:hasRegistrationCode
21/ 239/05-C
n3:hasTitleSupplement
POR CPS DUR 50X400MG
n3:containsUsualTherapeuticalDailyDoses
11.1111
n3:hasCoreReimbursementSpecification
n10:2014-05-01 n10:2014-06-01 n10:2014-03-01 n10:2014-04-01 n10:2014-07-03 n10:2014-08-01 n10:2014-06-13 n10:2014-07-01 n10:2014-10-02 n10:2014-11-01 n10:2014-09-01 n10:2014-10-01 n10:2015-01-01 n10:2015-01-13 n10:2014-11-19 n10:2014-12-01 n10:2013-02-01 n10:2013-03-01 n10:2013-01-01 n10:2013-01-05 n10:2013-06-01 n10:2013-07-01 n10:2013-04-01 n10:2013-05-01 n10:2013-09-01 n10:2013-10-01 n10:2013-08-01 n10:2013-08-03 n10:2014-01-01 n10:2014-02-01 n10:2013-11-01 n10:2013-12-01 n10:2015-04-01 n10:2015-04-02 n10:2015-02-01 n10:2015-03-01 n10:2015-07-01 n10:2015-07-02 n10:2015-05-01 n10:2015-06-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n12:2015-07-01 n12:2015-07-02 n12:2015-05-01 n12:2015-06-01 n12:2015-04-01 n12:2015-04-02 n12:2015-02-01 n12:2015-03-01 n12:2015-01-01 n12:2015-01-13 n12:2014-11-19 n12:2014-12-01 n12:2014-10-02 n12:2014-11-01 n12:2014-09-01 n12:2014-10-01 n12:2013-06-01 n12:2013-07-01 n12:2013-04-01 n12:2013-05-01 n12:2013-02-01 n12:2013-03-01 n12:2013-01-01 n12:2013-01-05 n12:2014-07-03 n12:2014-08-01 n12:2014-06-13 n12:2014-07-01 n12:2014-05-01 n12:2014-06-01 n12:2014-03-01 n12:2014-04-01 n12:2014-01-01 n12:2014-02-01 n12:2013-11-01 n12:2013-12-01 n12:2013-09-01 n12:2013-10-01 n12:2013-08-01 n12:2013-08-03
n3:hasPriceSpecification
n9:2014-09-01 n9:2014-10-01 n9:2014-10-02 n9:2014-11-01 n9:2014-11-19 n9:2014-12-01 n9:2015-01-01 n9:2015-01-13 n9:2014-03-01 n9:2014-04-01 n9:2014-05-01 n9:2014-06-01 n9:2014-06-13 n9:2014-07-01 n9:2014-07-03 n9:2014-08-01 n9:2015-02-01 n9:2015-03-01 n9:2015-04-01 n9:2015-04-02 n9:2015-05-01 n9:2015-06-01 n9:2015-07-01 n9:2015-07-02 n9:2013-08-01 n9:2013-08-03 n9:2013-09-01 n9:2013-10-01 n9:2013-11-01 n9:2013-12-01 n9:2014-01-01 n9:2014-02-01 n9:2013-01-01 n9:2013-01-05 n9:2013-02-01 n9:2013-03-01 n9:2013-04-01 n9:2013-05-01 n9:2013-06-01 n9:2013-07-01
n3:hasReimbursementSpecification
n8:2014-05-01 n8:2014-06-01 n8:2014-03-01 n8:2014-04-01 n8:2014-07-03 n8:2014-08-01 n8:2014-06-13 n8:2014-07-01 n8:2013-09-01 n8:2013-10-01 n8:2013-08-01 n8:2013-08-03 n8:2014-01-01 n8:2014-02-01 n8:2013-11-01 n8:2013-12-01 n8:2015-04-01 n8:2015-04-02 n8:2015-02-01 n8:2015-03-01 n8:2015-07-01 n8:2013-02-01 n8:2015-07-02 n8:2015-05-01 n8:2013-03-01 n8:2015-06-01 n8:2013-01-01 n8:2014-10-02 n8:2013-01-05 n8:2014-11-01 n8:2013-06-01 n8:2014-09-01 n8:2013-07-01 n8:2014-10-01 n8:2013-04-01 n8:2015-01-01 n8:2013-05-01 n8:2015-01-13 n8:2014-11-19 n8:2014-12-01
n3:hasResumedMarketingDate
2010-02-01+01:00
n3:hasUsualTherapeuticalDailyDose
n4:utdd
n3:spcFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC64022.pdf%26type%3Dspc%26as%3Dgabapentin-teva-400-mg-spc
n3:spcUri
n7:download.php?file=SPC64022.pdf&type=spc&as=gabapentin-teva-400-mg-spc